JP2023548580A5 - - Google Patents
Info
- Publication number
- JP2023548580A5 JP2023548580A5 JP2023527226A JP2023527226A JP2023548580A5 JP 2023548580 A5 JP2023548580 A5 JP 2023548580A5 JP 2023527226 A JP2023527226 A JP 2023527226A JP 2023527226 A JP2023527226 A JP 2023527226A JP 2023548580 A5 JP2023548580 A5 JP 2023548580A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- bacteriophage
- phage
- crispr
- sequence identity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063110107P | 2020-11-05 | 2020-11-05 | |
| US63/110,107 | 2020-11-05 | ||
| US202163184647P | 2021-05-05 | 2021-05-05 | |
| US63/184,647 | 2021-05-05 | ||
| PCT/US2021/058095 WO2022098899A1 (en) | 2020-11-05 | 2021-11-04 | Phage compositions for escherichia comprising crispr-cas systems and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023548580A JP2023548580A (ja) | 2023-11-17 |
| JP2023548580A5 true JP2023548580A5 (https=) | 2024-11-13 |
Family
ID=81458374
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023527226A Pending JP2023548580A (ja) | 2020-11-05 | 2021-11-04 | Ｃｒｉｓｐｒ－ｃａｓ系を含むエシェリキア属に対するファージ組成物およびその使用方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230398161A1 (https=) |
| EP (1) | EP4247942A4 (https=) |
| JP (1) | JP2023548580A (https=) |
| AU (1) | AU2021372972A1 (https=) |
| CA (1) | CA3197277A1 (https=) |
| WO (1) | WO2022098899A1 (https=) |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107208070B (zh) * | 2014-11-26 | 2021-09-07 | 技术创新动力基金（以色列）有限合伙公司 | 细菌基因的靶向消除 |
| WO2016205276A1 (en) * | 2015-06-15 | 2016-12-22 | North Carolina State University | Methods and compositions for efficient delivery of nucleic acids and rna-based antimicrobials |
| US11311582B2 (en) * | 2015-11-19 | 2022-04-26 | Locus Biosciences, Inc. | Bacteriophage compositions and methods of use thereof |
| US9896696B2 (en) * | 2016-02-15 | 2018-02-20 | Benson Hill Biosystems, Inc. | Compositions and methods for modifying genomes |
| GB201710126D0 (en) * | 2017-06-25 | 2017-08-09 | Snipr Tech Ltd | Vectors & Methods |
| JP2020525049A (ja) * | 2017-06-25 | 2020-08-27 | エスエヌアイピーアール・テクノロジーズ・リミテッドＳｎｉｐｒ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｌｉｍｉｔｅｄ | 微生物集団の変更及び細菌叢の改変 |
| US20190160120A1 (en) * | 2017-11-29 | 2019-05-30 | Snipr Biome Aps | Dna, methods etc |
| CA3099316A1 (en) * | 2018-05-04 | 2019-11-07 | Locus Biosciences, Inc. | Methods and compositions for killing a target bacterium |
| WO2019227080A1 (en) * | 2018-05-25 | 2019-11-28 | Locus Biosciences, Inc. | Methods and compositions for killing a target bacterium |
| CN114981418A (zh) * | 2019-11-06 | 2022-08-30 | 洛可斯生物科学公司 | 包含crispr-cas系统的噬菌体组合物及其使用方法 |
| WO2021092254A1 (en) * | 2019-11-06 | 2021-05-14 | Locus Biosciences, Inc. | Phage compositions comprising crispr-cas systems and methods of use thereof |
-
2021
- 2021-11-04 CA CA3197277A patent/CA3197277A1/en active Pending
- 2021-11-04 WO PCT/US2021/058095 patent/WO2022098899A1/en not_active Ceased
- 2021-11-04 JP JP2023527226A patent/JP2023548580A/ja active Pending
- 2021-11-04 EP EP21890081.9A patent/EP4247942A4/en active Pending
- 2021-11-04 AU AU2021372972A patent/AU2021372972A1/en active Pending
- 2021-11-04 US US18/033,988 patent/US20230398161A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12246061B2 (en) | Sequence specific antimicrobials | |
| Mesyanzhinov et al. | The genome of bacteriophage φKZ of Pseudomonas aeruginosa | |
| Miller et al. | Bacteriophage T4 genome | |
| Cazares et al. | Core and accessory genome architecture in a group of Pseudomonas aeruginosa Mu-like phages | |
| JP2025114562A (ja) | 非組み込みウイルス送達システムおよびその使用の方法 | |
| US12378577B2 (en) | Crispr-CAS10 systems and methods for phage genome editing | |
| JP2008533988A5 (https=) | ||
| WO2020007325A1 (en) | Cas9 variants and application thereof | |
| JP2023548581A5 (https=) | ||
| Innamorati et al. | The bacterial guide to designing a diversified gene portfolio | |
| Mosterd et al. | Characterization of a type II-A CRISPR-Cas system in Streptococcus mutans | |
| AU2022284287A1 (en) | Rna-guided casω nucleases and uses thereof in diagnostics and therapy | |
| Li et al. | A novel Saclayvirus Acinetobacter baumannii phage genomic analysis and effectiveness in preventing pneumonia | |
| Stevens et al. | The annotated complete DNA sequence of Enterococcus faecalis bacteriophage φEf11 and its comparison with all available phage and predicted prophage genomes | |
| JP2023548580A5 (https=) | ||
| CN116410969A (zh) | 一种噬菌体、噬菌体裂解酶及其用途 | |
| JP2010512774A (ja) | バクテリオファージのスクリーニング蛋白質へのランダム配列挿入により改変されたバクテリオファージの作製方法 | |
| Arbiol et al. | Mobile regulatory cassettes mediate modular shuffling in T4-type phage genomes | |
| CN118460655B (zh) | 抑制FXI基因表达的siRNA的制备方法 | |
| JP2022552940A5 (https=) | ||
| WO2024173573A1 (en) | Crispr-transposon systems and components | |
| Mohammed et al. | Identification of a new antiphage system in Mycobacterium phage butters | |
| Anandu et al. | Anti-CRISPR: a defense strategy of bacteriophages against bacteria | |
| KR100599456B1 (ko) | ＨＩＶ ｐｓｉ에 대한 결합력이 증가된 ＮＣ 돌연변이체및 이를 함유하는 약학적 조성물 | |
| Reichmann et al. | Rhabdovirus defective particles: Origin and genome assignments |